TITLE

Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo

AUTHOR(S)
Nowak, G.; Ericzon, B.-G.; Nova, S.; Jaksch, M.; Westgren, M.; Sumifran-Holgersson, S.
PUB. DATE
July 2005
SOURCE
Gut;Jul2005, Vol. 54 Issue 7, p972
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: liver diseases include a wide spectrum of both acute and chronic conditions which are associated with significant morbidity and mortality worldwide. Hepatocyte transplantation has therapeutic potential in the treatment of liver diseases, but its clinical use is hampered by the lack of donor tissue. Generation of hepatocytes in vitro from adult or fetal liver cell progenitors or, alternatively, identification of a progenitor population which in vivo can generate mature liver cells could solve this problem. Methods: CD117+/CD34+/Lin— human fetal liver cells were isolated by magnetic cell sorting and expanded in culture. Both freshly isolated and in vitro expanded cells in various passages were studied for their ability to be functional in hepatic parenchyma following D-galactosamine (GalN) induced injury in nude C57 black mice. Results: Freshly isolated and in vitro expanded CD117+/CD34+/Lin— cells, when transplanted intrasplenically into GalN treated mice, morphologically and functionally differentiated into hepatocytes and cholangiocytes. Human specific albumin, α fetoprotein, cytokeratin 19, and antitrypsin mRNA were expressed in mouse liver. In addition, the human progenitor cells expressed glucose-6-phosphatase, glycogen, albumin, gamma glutamyl transpeptidase, and dipeptidyl peptidase IV after transplantation. Expanded cells in various passages maintained their capacity to differentiate into functional liver cells. Conclusions: Fetal liver CD117+/C034+/Lin— progenitors and their progeny proliferated in vitro and also functionally differentiated into mature hepatic cells in an acute liver injury model. Successful in vitro expansion of liver progenitor cells provides a basis for developing cell therapy strategies, metabolic and toxicity testing systems, and may serve as a vehicle for gene therapy.
ACCESSION #
17496267

 

Related Articles

  • Hepatocyte transplantation for metabolic liver disease: UK experience. Hughes, Robin D.; Mitry, Ragai R.; Dhawan, Anil // Journal of the Royal Society of Medicine;Aug2005, Vol. 98 Issue 8, p341 

    The article focuses on the use of hepatocyte transplantation for patients with metabolic liver disease in Great Britain. It also discusses the sources of hepatocytes, the isolation process, preclinical studies and clinical experience, especially in the treatment of liver-based inborn errors of...

  • Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver. Okumoto, Kazuo; Saito, Takafumi; Haga, Hiroaki; Hattori, Etsuko; Ishii, Rika; Karasawa, Tetsuru; Suzuki, Akihiko; Misawa, Keiko; Sanjo, Mai; Ito, Jun-itsu; Sugahara, Kazuhiko; Saito, Koji; Togashi, Hitoshi; Kawata, Sumio // Journal of Gastroenterology;Jan2006, Vol. 41 Issue 1, p62 

    Background. Bone marrow cells (BMCs) have been shown to differentiate into a liver cell lineage, but little is known about their dynamics following transplantation. BMCs were cultured to investigate the expression of liver-specific genes in vitro and transplanted into in vivo liver-injury models...

  • Isolation of Primary Human Hepatocytes from Normal and Diseased Liver Tissue: A One Hundred Liver Experience. Bhogal, Ricky H.; Hodson, James; Bartlett, David C.; Weston, Christopher J.; Curbishley, Stuart M.; Haughton, Emma; Williams, Kevin T.; Reynolds, Gary M.; Newsome, Phillip N.; Adams, David H.; Afford, Simon C. // PLoS ONE;2011, Vol. 6 Issue 3, p1 

    Successful and consistent isolation of primary human hepatocytes remains a challenge for both cell-based therapeutics/ transplantation and laboratory research. Several centres around the world have extensive experience in the isolation of human hepatocytes from non-diseased livers obtained from...

  • Stem Cells and Liver Disease. Akhter, Javed; Ali Aziz, Ashraf; Al Ajlan, Abdulaziz // Internet Journal of Medical Update;Jul2011, Vol. 6 Issue 2, p69 

    Liver transplantation is the primary treatment for various end-stage hepatic diseases but is hindered by the lack of donor organs, complications associated with rejection and immunosuppression. An increasingly unbridgeable gap exists between the supply and demand of transplantable organs. Hence...

  • HIV-1 Matrix Dependent Membrane Targeting Is Regulated by Gag mRNA Trafficking. Jing Jin; Sturgeon, Timothy; Weisz, Ora A.; Mothes, Walther; Montelaro, Ronald C. // PLoS ONE;2009, Vol. 4 Issue 8, p1 

    Retroviral Gag polyproteins are necessary and sufficient for virus budding. Productive HIV-1 Gag assembly takes place at the plasma membrane. However, little is known about the mechanisms by which thousands of Gag molecules are targeted to the plasma membrane. Using a bimolecular fluorescence...

  • Liver Development and In vitro Differentiation of Embryonic Stem Cells to Hepatocytes. Pournasr, Behshad; Farzaneh, Zahra; Shahsanvani, Mansoureh; Baharvand, Hossein // Yakhteh Medical Journal;Winter2010, Vol. 11 Issue 4, p348 

    Embryonic stem cells are characterized with two specific properties: self renewal and differentiation potential. Embryonic stem cells are pluripotent cells that can be differentiated into three kind of germ layers; ectoderm, endoderm, mesoderm. These properties make them ideal for developmental...

  • Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Sancho-Bru, P.; Najimi, M.; Caruso, M.; Pauwelyn, K.; Cantz, T.; Forbes, S.; Roskams, T.; Ott, M.; Gehling, U.; Sokal, E.; Verfaillie, C. M.; Muraca, M. // Gut;Apr2009, Vol. 58 Issue 4, p594 

    There has been recent progress in the isolation and characterisation of stem/progenitor cells that may differentiate towards the hepatic lineage. This has raised expectations that therapy of genetic or acquired liver disease might be possible by transplanting stem/progenitor cells or their...

  • Transplantation-Based Gene Therapy for Inflammatory Diseases Focus on Glomerulonephritis. Yokoo, T.; Ohashi, T. // Current Gene Therapy;Jul2001, Vol. 1 Issue 2, p227 

    Over the past decade, bone marrow transplantation has come to be considered an ideal therapeutic strategy for the treatment of certain diseases affecting the hematopoietic system such as hemophilia, and several clinical trials have Been performed. Although traditionally used for the treatment of...

  • Gene therapy in transplantation in the year 2000: moving towards clinical applications? Guillot, C; Le Mauff, B; Cuturi, M C; Anegon, I // Gene Therapy;Jan2000, Vol. 7 Issue 1, p14 

    Transplantation faces several major obstacles that could be overcome by expression of immunomodulatory proteins through application of gene therapy techniques. Gene therapy strategies to prolong graft survival involve gene transfer of immunosuppressive or graft-protecting molecules. Very...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics